AU2005258078B2 - Methods of treatment of endobronchial infections - Google Patents

Methods of treatment of endobronchial infections Download PDF

Info

Publication number
AU2005258078B2
AU2005258078B2 AU2005258078A AU2005258078A AU2005258078B2 AU 2005258078 B2 AU2005258078 B2 AU 2005258078B2 AU 2005258078 A AU2005258078 A AU 2005258078A AU 2005258078 A AU2005258078 A AU 2005258078A AU 2005258078 B2 AU2005258078 B2 AU 2005258078B2
Authority
AU
Australia
Prior art keywords
tobramycin
treatment
composition
dry powder
subjects
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU2005258078A
Other languages
English (en)
Other versions
AU2005258078A1 (en
Inventor
Peter Challoner
John D. Lord
Carlos Rodriguez
Emil Samara
Thomas E. Tarara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BGP Products Operations GmbH
Original Assignee
BGP Products Operations GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BGP Products Operations GmbH filed Critical BGP Products Operations GmbH
Publication of AU2005258078A1 publication Critical patent/AU2005258078A1/en
Assigned to NOVARTIS AG, NOVARTIS VACCINES AND DIAGNOSTICS INC. reassignment NOVARTIS AG Request for Assignment Assignors: NEKTAR THERAPEUTICS, NOVARTIS VACCINES AND DIAGNOSTICS INC.
Application granted granted Critical
Publication of AU2005258078B2 publication Critical patent/AU2005258078B2/en
Assigned to NOVARTIS AG reassignment NOVARTIS AG Request for Assignment Assignors: NOVARTIS AG, NOVARTIS VACCINES AND DIAGNOSTICS INC.
Assigned to BGP PRODUCTS OPERATIONS GMBH reassignment BGP PRODUCTS OPERATIONS GMBH Request for Assignment Assignors: NOVARTIS AG
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2005258078A 2004-06-18 2005-06-20 Methods of treatment of endobronchial infections Expired AU2005258078B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58084804P 2004-06-18 2004-06-18
US60/580,848 2004-06-18
PCT/US2005/021952 WO2006002178A1 (en) 2004-06-18 2005-06-20 Methods of treatment of endobronchial infections

Publications (2)

Publication Number Publication Date
AU2005258078A1 AU2005258078A1 (en) 2006-01-05
AU2005258078B2 true AU2005258078B2 (en) 2010-09-30

Family

ID=35782127

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005258078A Expired AU2005258078B2 (en) 2004-06-18 2005-06-20 Methods of treatment of endobronchial infections

Country Status (25)

Country Link
US (3) US20080214481A1 (enExample)
EP (1) EP1765288B1 (enExample)
JP (3) JP2008503500A (enExample)
KR (2) KR20070026604A (enExample)
CN (1) CN101014320B (enExample)
AU (1) AU2005258078B2 (enExample)
BR (1) BRPI0512146A (enExample)
CA (1) CA2570976C (enExample)
DK (1) DK1765288T3 (enExample)
EC (1) ECSP077182A (enExample)
ES (1) ES2399279T3 (enExample)
HR (1) HRP20130076T1 (enExample)
IL (1) IL179873A (enExample)
MA (1) MA28740B1 (enExample)
MX (1) MXPA06014567A (enExample)
NO (1) NO338799B1 (enExample)
NZ (1) NZ552047A (enExample)
PL (1) PL1765288T3 (enExample)
PT (1) PT1765288E (enExample)
RU (1) RU2389477C2 (enExample)
SG (1) SG153833A1 (enExample)
SI (1) SI1765288T1 (enExample)
TN (1) TNSN06420A1 (enExample)
WO (1) WO2006002178A1 (enExample)
ZA (1) ZA200700420B (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003053411A1 (en) 2001-12-19 2003-07-03 Nektar Therapeutics Pulmonary delivery of aminoglycosides
US7381184B2 (en) 2002-11-05 2008-06-03 Abbott Diabetes Care Inc. Sensor inserter assembly
USD902408S1 (en) 2003-11-05 2020-11-17 Abbott Diabetes Care Inc. Analyte sensor control unit
US10226207B2 (en) 2004-12-29 2019-03-12 Abbott Diabetes Care Inc. Sensor inserter having introducer
US7883464B2 (en) 2005-09-30 2011-02-08 Abbott Diabetes Care Inc. Integrated transmitter unit and sensor introducer mechanism and methods of use
US9259175B2 (en) 2006-10-23 2016-02-16 Abbott Diabetes Care, Inc. Flexible patch for fluid delivery and monitoring body analytes
US9788771B2 (en) 2006-10-23 2017-10-17 Abbott Diabetes Care Inc. Variable speed sensor insertion devices and methods of use
US8512243B2 (en) 2005-09-30 2013-08-20 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US7697967B2 (en) 2005-12-28 2010-04-13 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US9398882B2 (en) 2005-09-30 2016-07-26 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor and data processing device
US8029441B2 (en) 2006-02-28 2011-10-04 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US8333714B2 (en) 2006-09-10 2012-12-18 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US9521968B2 (en) 2005-09-30 2016-12-20 Abbott Diabetes Care Inc. Analyte sensor retention mechanism and methods of use
US11298058B2 (en) 2005-12-28 2022-04-12 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
CA2665764C (en) 2006-10-11 2015-05-26 Laboratoires Smb S.A. Pharmaceutical anti-infective composition for inhalation
EP1938822A1 (en) * 2006-12-21 2008-07-02 Novartis AG Combination therapy for the treatment of airways disease
KR101621986B1 (ko) * 2008-05-15 2016-05-17 노파르티스 아게 플루오로퀴놀론의 폐 전달
US9402544B2 (en) 2009-02-03 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
TWI792140B (zh) * 2009-05-29 2023-02-11 美商沛爾醫療股份有限公司 用於經由呼吸道遞送二或更多種活性藥劑的組成物、方法與系統
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
CN102473276B (zh) 2009-08-31 2016-04-13 雅培糖尿病护理公司 医疗装置及方法
CA2784207C (en) * 2009-12-14 2018-06-05 Chiesi Farmaceutici S.P.A. Antibiotic microparticles for inhalation
BRPI1105778A2 (pt) 2010-03-24 2016-05-03 Abbott Diabetes Care Inc "insersores de dispositivo médico e processos de inserção e uso de dispositivos médicos"
US11064921B2 (en) 2010-06-29 2021-07-20 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US9572774B2 (en) 2011-05-19 2017-02-21 Savara Inc. Dry powder vancomycin compositions and associated methods
US8826904B2 (en) 2011-07-12 2014-09-09 Cardeas Pharma Corporation Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
BR112014000275A2 (pt) 2011-07-12 2017-04-18 Cardeas Pharma Inc formulações aperfeiçoadas de combinações de aminoglicosídeo e fosfomicina e métodos e sistemas para o tratamento de pneumonia associada à ventilação mecânica (pavm) e traqueobronquite associada à ventilação mecânica (vat)
WO2013090215A2 (en) 2011-12-11 2013-06-20 Abbot Diabetes Care Inc. Analyte sensor devices, connections, and methods
WO2014055456A1 (en) * 2012-10-07 2014-04-10 Abbott Diabetes Care Inc. Medical device insertion indicators
CN102949379B (zh) * 2012-11-14 2014-11-05 中山大学 硫酸奈替米星吸入粉雾剂及其制备方法
SG11201507286QA (en) 2013-03-15 2015-10-29 Pearl Therapeutics Inc Methods and systems for conditioning of particulate crystalline materials
US10674944B2 (en) 2015-05-14 2020-06-09 Abbott Diabetes Care Inc. Compact medical device inserters and related systems and methods
US10213139B2 (en) 2015-05-14 2019-02-26 Abbott Diabetes Care Inc. Systems, devices, and methods for assembling an applicator and sensor control device
CN110461217B (zh) 2017-01-23 2022-09-16 雅培糖尿病护理公司 用于分析物传感器插入的系统、装置和方法
WO2020163416A1 (en) * 2019-02-05 2020-08-13 Mylan Inc Devices and methods for tobramycin inhalation treatment
USD1002852S1 (en) 2019-06-06 2023-10-24 Abbott Diabetes Care Inc. Analyte sensor device
CA3188510A1 (en) 2020-08-31 2022-03-03 Vivek S. RAO Systems, devices, and methods for analyte sensor insertion
USD999913S1 (en) 2020-12-21 2023-09-26 Abbott Diabetes Care Inc Analyte sensor inserter

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6387886B1 (en) * 1998-12-17 2002-05-14 Chiron Corporation Method for the treatment of severe chronic bronchitis (bronchietasis) with an aerosolized antibiotic

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5A (en) * 1836-08-10 Thomas Blanchard Machine for mortising solid wooden shells of ships' tackle-blocks
FR2224175B1 (enExample) 1973-04-04 1978-04-14 Isf Spa
US4069819A (en) 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
IT1017153B (it) 1974-07-15 1977-07-20 Isf Spa Apparecchio per inalazioni
SE438261B (sv) 1981-07-08 1985-04-15 Draco Ab Anvendning i dosinhalator av ett perforerat membran
GB8314308D0 (en) 1983-05-24 1983-06-29 Matburn Holdings Ltd Medical administration devices
SU1335297A1 (ru) * 1984-06-15 1987-09-07 Донецкий медицинский институт им.М.Горького Способ лечени больных хроническими заболевани ми легких
US4805811A (en) 1985-03-29 1989-02-21 Aktiebolaget Draco Dosage device
SE448277B (sv) 1985-04-12 1987-02-09 Draco Ab Indikeringsanordning vid en doseringsanordning for lekemedel
IT1228459B (it) 1989-02-23 1991-06-19 Phidea S R L Inalatore con svuotamento regolare e completo della capsula.
GB8909891D0 (en) 1989-04-28 1989-06-14 Riker Laboratories Inc Device
IT1243344B (it) 1990-07-16 1994-06-10 Promo Pack Sa Inalatore plurimonodose per medicamenti in polvere
CA2112674C (en) 1991-07-02 2005-10-04 John S. Patton Method and device for delivering aerosolized medicaments
US5785049A (en) 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
IS1736B (is) 1993-10-01 1999-12-30 Astra Ab Aðferð og tæki sem stuðla að aukinni samloðun agna
US5388572A (en) 1993-10-26 1995-02-14 Tenax Corporation (A Connecticut Corp.) Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
WO1995031479A1 (en) 1994-05-18 1995-11-23 Inhale Therapeutic Systems, Inc. Methods and compositions for the dry powder formulation of interferons
CZ289029B6 (cs) 1994-09-21 2001-10-17 Inhale Therapeutic Systems Způsob aerosolizace práąku, zejména práąkového léku a zařízení k provádění tohoto způsobu
US5522385A (en) 1994-09-27 1996-06-04 Aradigm Corporation Dynamic particle size control for aerosolized drug delivery
US5508269A (en) * 1994-10-19 1996-04-16 Pathogenesis Corporation Aminoglycoside formulation for aerosolization
ES2237767T3 (es) 1995-04-14 2005-08-01 Nektar Therapeutics Composiciones farmaceuticas en polvo que tienen una dispersabilidad mejorada.
US5826633A (en) 1996-04-26 1998-10-27 Inhale Therapeutic Systems Powder filling systems, apparatus and methods
WO1999061003A1 (en) * 1998-05-27 1999-12-02 Euroceltique S.A. Drug delivery system comprising a tightly compacted solid medicament stock
US6586008B1 (en) 1999-08-25 2003-07-01 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles during spray drying
CA2382821A1 (en) 1999-08-25 2001-03-01 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
CA2382133C (en) 2000-05-10 2010-11-23 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
US6613308B2 (en) 2000-09-19 2003-09-02 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
PT1320355E (pt) 2001-05-18 2006-08-31 Chiron Corp Sistema para administracao de uma formulacao de tobramicina
DE10131917A1 (de) 2001-07-02 2003-01-23 Infineon Technologies Ag Verfahren zur Erzeugung einer stufenförmigen Struktur auf einem Substrat
ATE509651T1 (de) 2001-11-14 2011-06-15 Novartis Ag Aerosol-vernebler bestehend aus koppelbarem haupt-und endstück
US20030094173A1 (en) 2001-11-14 2003-05-22 Inhale Therapeutic Systems, Inc. Aerosolization device with improved endpiece connection
WO2003053411A1 (en) 2001-12-19 2003-07-03 Nektar Therapeutics Pulmonary delivery of aminoglycosides
JP4739672B2 (ja) 2001-12-21 2011-08-03 ネクター セラピューティクス 湿気のバリアを有するカプセルパッケージ
KR20050003416A (ko) 2002-05-07 2005-01-10 넥타르 테라퓨틱스 건조분말 흡입기용 캡슐 및 이의 제조 및 사용 방법
CN1493297A (zh) * 2003-09-13 2004-05-05 南昌弘益科技有限公司 妥布霉素吸入粉雾剂及其制备方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6387886B1 (en) * 1998-12-17 2002-05-14 Chiron Corporation Method for the treatment of severe chronic bronchitis (bronchietasis) with an aerosolized antibiotic

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GELLER D. E et al: "Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis." CHEST July 2002 *

Also Published As

Publication number Publication date
RU2389477C2 (ru) 2010-05-20
CN101014320B (zh) 2011-05-18
HRP20130076T1 (hr) 2013-03-31
BRPI0512146A (pt) 2008-02-12
MXPA06014567A (es) 2007-07-24
US20110097412A1 (en) 2011-04-28
NO338799B1 (no) 2016-10-24
IL179873A0 (en) 2007-05-15
ZA200700420B (en) 2008-05-28
AU2005258078A1 (en) 2006-01-05
MA28740B1 (fr) 2007-07-02
WO2006002178A1 (en) 2006-01-05
KR20070026604A (ko) 2007-03-08
KR20120131245A (ko) 2012-12-04
TNSN06420A1 (en) 2008-02-22
CA2570976A1 (en) 2006-01-05
PT1765288E (pt) 2013-01-29
IL179873A (en) 2014-09-30
JP2012107047A (ja) 2012-06-07
EP1765288A4 (en) 2009-05-13
JP2013056947A (ja) 2013-03-28
CA2570976C (en) 2013-08-13
DK1765288T3 (da) 2013-02-11
NZ552047A (en) 2009-11-27
US20120148641A1 (en) 2012-06-14
SG153833A1 (en) 2009-07-29
EP1765288B1 (en) 2012-11-07
JP2008503500A (ja) 2008-02-07
US8664187B2 (en) 2014-03-04
PL1765288T3 (pl) 2013-04-30
RU2007101906A (ru) 2008-07-27
ES2399279T3 (es) 2013-03-27
CN101014320A (zh) 2007-08-08
NO20070253L (no) 2007-03-13
SI1765288T1 (sl) 2013-02-28
EP1765288A1 (en) 2007-03-28
ECSP077182A (es) 2007-05-30
US20080214481A1 (en) 2008-09-04

Similar Documents

Publication Publication Date Title
AU2005258078B2 (en) Methods of treatment of endobronchial infections
Geller et al. Novel tobramycin inhalation powder in cystic fibrosis subjects: pharmacokinetics and safety
EP1320355B1 (en) System for delivering a tobramycin formulation
AU2002231244B2 (en) Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections
US6387886B1 (en) Method for the treatment of severe chronic bronchitis (bronchietasis) with an aerosolized antibiotic
Hatipoglu et al. Pharmacokinetics and pharmacodynamics of high doses of inhaled dry powder drugs
AU2002231244A1 (en) Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections
JP2017530993A (ja) 配合物の安定性を高めるために噴霧乾燥によって得られる少なくとも１種の乾燥粉末を含む組成物
Debnath et al. Status of inhalable antimicrobial agents for lung infection: progress and prospects
Balducci et al. Drug delivery strategies for pulmonary administration of antibiotics
CN101951906A (zh) 用于治疗肺病中的健康相关生命质量缺陷的吸入式氨曲南赖氨酸
Hoppentocht et al. European Journal of Pharmaceutics and Biopharmaceutics, 2013, 86 (1), p. 23-30

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: ADD CO-INVENTOR SAMARA, EMIL

PC1 Assignment before grant (sect. 113)

Owner name: NOVARTIS AG; NOVARTIS VACCINES AND DIAGNOSTICS INC

Free format text: FORMER APPLICANT(S): NOVARTIS VACCINES AND DIAGNOSTICS INC.; NEKTAR THERAPEUTICS

FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: NOVARTIS AG

Free format text: FORMER OWNER WAS: NOVARTIS AG; NOVARTIS VACCINES AND DIAGNOSTICS INC.

PC Assignment registered

Owner name: BGP PRODUCTS OPERATIONS GMBH

Free format text: FORMER OWNER(S): NOVARTIS AG

MK14 Patent ceased section 143(a) (annual fees not paid) or expired